Search filters

List of works by Jolanda de Vries

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.

scientific article published on 07 February 2016

A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies

scientific article published on 02 May 2022

A large-scale 19F MRI-based cell migration assay to optimize cell therapy

scientific article published on 07 February 2012

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients.

scientific article published on 5 October 2010

A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery

scientific article published on 31 May 2021

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.

scientific article published on 29 July 2016

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients.

scientific article published on 31 May 2016

An Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT.

scientific article published on 04 September 2013

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

scientific article published on 24 January 2020

Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination.

scientific article

Cell tracking using (19)F magnetic resonance imaging: technical aspects and challenges towards clinical applications.

scientific article

Cell tracking using multimodal imaging.

scientific article

Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis

scientific article published on 01 February 2016

DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells

scientific article published on 17 March 2011

Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.

scientific article published on April 2016

Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination.

scientific article

Dendritic cell vaccination in melanoma patients: From promising results to future perspectives

scientific article published on 20 June 2016

Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging.

scientific article published on 24 October 2011

Early predictive value of multifunctional skin-infiltrating lymphocytes in anticancer immunotherapy

scientific article published on January 2014

Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment

scientific article published on 15 November 2017

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.

scientific article published on 12 April 2015

Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.

scientific article published on 20 June 2016

Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination.

scientific article published on 5 June 2015

Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents

scientific article published on 21 December 2010

Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis

scientific article published on 23 April 2012

Harnessing human plasmacytoid dendritic cells as professional APCs.

scientific article published on August 2012

Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy

article

Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.

scientific article published on 02 September 2016

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.

scientific article published on 10 September 2012

Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.

scientific article published on 4 December 2012

Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue

scientific article published in July 2015

Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters ⬇️

scientific article published on April 21, 2012

IL-4 and IL-13 alter plasmacytoid dendritic cell responsiveness to CpG DNA and herpes simplex virus-1.

scientific article published on 30 December 2010

Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients

Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients.

scientific article published on 25 May 2016

Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens.

scientific article published on 06 May 2014

Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy.

scientific article published on 14 May 2013

Improving cancer immunotherapy by targeting the STATe of MDSCs

scientific article

In vivo imaging of therapy-induced anti-cancer immune responses in humans ⬇️

scientific article published on October 5, 2012

In vivo tracking techniques for cellular regeneration, replacement, and redirection.

scientific article

Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients

scientific article published on April 2015

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination

scientific article published on 17 June 2016

Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients

scientific article published on 17 July 2014

Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination

scientific article published on 12 August 2015

Molecular pathways: the immunogenic effects of platinum-based chemotherapeutics.

scientific article published on June 2014

Multispectral imaging for highly accurate analysis of tumour-infiltrating lymphocytes in primary melanoma

scientific article

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

article

Naturally circulating dendritic cells to vaccinate cancer patients.

scientific article published on March 2013

Opportunities for immunotherapy in microsatellite instable colorectal cancer

scientific article

PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19F MRI.

scientific article published on 7 August 2015

Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets.

scientific article published on 11 April 2014

Potential applications for plasmacytoid dendritic cells in cancer immunotherapy.

scientific article published in October 2012

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition.

scientific article published on 14 April 2016

Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.

scientific article

Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses.

scientific article published on 22 January 2011

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets

scientific article published on 15 August 2015

Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function

scientific article

Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect

scientific article published on 23 December 2015

Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination

scientific article published on 30 April 2013

Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment

scientific article

Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients

scientific article published on 19 July 2011

STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics

scientific article published on 11 June 2019

STATing the importance of immune modulation by platinum chemotherapeutics ⬇️

scientific article published on March 1, 2012

Scientific contributions toward successful cancer immunotherapy in The Netherlands.

scientific article published on 16 October 2014

Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell-Based Vaccination in Metastatic Melanoma

scientific article published on 24 September 2012

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.

scientific article

T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines

scientific article published on 11 April 2016

Targeted delivery of CpG ODN to CD32 on human and monkey plasmacytoid dendritic cells augments IFNα secretion.

scientific article

Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion

scientific article published on 14 October 2013

Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells

scientific article published on 04 February 2013

The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells

scientific article published on 10 January 2012

The lymphoid chemokine CCL21 triggers LFA-1 adhesive properties on human dendritic cells

scientific article published on 31 August 2010

The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture

scientific article published on 02 June 2020

Tumoricidal activity of human dendritic cells.

scientific article

Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists

scientific article

Unraveling the human dendritic cell phagosome proteome by organellar enrichment ranking

scientific article published on 03 December 2011

Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients

article

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used

article

Paulina is supported by:

About Paulina

Help